• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bladder cancer: state-of-the-art care.

作者信息

Droller M J

机构信息

Department of Urology, Mount Sinai Medical Center, New York, NY, USA.

出版信息

CA Cancer J Clin. 1998 Sep-Oct;48(5):269-84. doi: 10.3322/canjclin.48.5.269.

DOI:10.3322/canjclin.48.5.269
PMID:9742894
Abstract

The challenge in bladder cancer is to control superficial disease and prevent its recurrence or progression. Patients with invasive disease need to be identified earlier, when disease may be less advanced and more amenable to cure. An important area for further investigation is the biology of the various forms of bladder cancer and the various pathways of development they may follow.

摘要

相似文献

1
Bladder cancer: state-of-the-art care.
CA Cancer J Clin. 1998 Sep-Oct;48(5):269-84. doi: 10.3322/canjclin.48.5.269.
2
[Diagnosis and therapy of bladder cancer].
MMW Fortschr Med. 2015 Nov 19;157(20):42-5. doi: 10.1007/s15006-015-7539-4.
3
Staging and prognosis of T3b bladder cancer.T3b期膀胱癌的分期与预后
Semin Urol Oncol. 1996 May;14(2):56-61.
4
Current concepts in assessment and treatment of bladder cancer.
Curr Opin Urol. 2000 Jul;10(4):291-9. doi: 10.1097/00042307-200007000-00002.
5
[Prognostic factors in urothelial carcinoma].[尿路上皮癌的预后因素]
Urologe A. 2001 Nov;40(6):442-6. doi: 10.1007/s001200170002.
6
The challenge of improved diagnostic and prognostic indicators of superficial bladder cancer.
J Urol. 2000 Sep;164(3 Pt 1):690-1. doi: 10.1097/00005392-200009010-00017.
7
Diagnosis and staging of bladder cancer.膀胱癌的诊断与分期
Hematol Oncol Clin North Am. 2015 Apr;29(2):205-18, vii. doi: 10.1016/j.hoc.2014.10.013. Epub 2014 Nov 6.
8
Imaging in oncology from the University of Texas M. D. Anderson Cancer Center. Imaging in the diagnosis, staging, and follow-up of cancer of the urinary bladder.
AJR Am J Roentgenol. 2003 Apr;180(4):1045-54. doi: 10.2214/ajr.180.4.1801045.
9
Follow-up imaging of bladder carcinoma. American College of Radiology. ACR Appropriateness Criteria.膀胱癌的随访影像学检查。美国放射学会。ACR适宜性标准。
Radiology. 2000 Jun;215 Suppl:765-72.
10
[Therapy and follow-up of bladder cancer].[膀胱癌的治疗与随访]
Wien Med Wochenschr. 2007;157(7-8):162-9. doi: 10.1007/s10354-007-0381-2.

引用本文的文献

1
Natural history of bladder cancer: Validation of the multiple pathway model in multi-omics era.膀胱癌的自然史:多组学时代多途径模型的验证
Urol Oncol. 2025 Feb;43(2):88-93. doi: 10.1016/j.urolonc.2024.10.003.
2
Partial cystectomy as a surgical option for colorectal cancer patients with pathological bladder invasion: an original retrospective study.对于伴有病理性膀胱侵犯的结直肠癌患者,部分膀胱切除术作为一种手术选择:一项原始回顾性研究。
Therap Adv Gastroenterol. 2025 Jan 3;18:17562848241308387. doi: 10.1177/17562848241308387. eCollection 2025.
3
The influence of post-diuretic late phase imaging in visual and quantitative evaluation of urothelial tumors by F-18 fluorodeoxyglucose positron emission tomography/computed tomography.
利尿后期成像对F-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在尿路上皮肿瘤视觉和定量评估中的影响。
Turk J Urol. 2019 Dec;45(Supp. 1):S56-S62. doi: 10.5152/tud.2019.27482. Epub 2019 Dec 1.
4
Identification of Four Immune Subtypes in Bladder Cancer Based on Immune Gene Sets.基于免疫基因集的膀胱癌四种免疫亚型的鉴定
Front Oncol. 2020 Oct 5;10:544610. doi: 10.3389/fonc.2020.544610. eCollection 2020.
5
In Vitro and In Vivo Antitumor Efficacy of Celluclast Extract against Bladder Cancer.纤维素酶提取物对膀胱癌的体外和体内抗肿瘤疗效。
Nutrients. 2020 Jul 21;12(7):2159. doi: 10.3390/nu12072159.
6
Increased expression of Psoriasin is correlated with poor prognosis of bladder transitional cell carcinoma by promoting invasion and proliferation.Psoriasin 的高表达与膀胱癌不良预后相关,可促进肿瘤侵袭和增殖。
Oncol Rep. 2020 Feb;43(2):562-570. doi: 10.3892/or.2019.7445. Epub 2019 Dec 24.
7
Application of fluorescence hybridization in the detection of bladder transitional-cell carcinoma: A multi-center clinical study based on Chinese population.荧光杂交技术在膀胱移行细胞癌检测中的应用:一项基于中国人群的多中心临床研究。
Asian J Urol. 2019 Jan;6(1):114-121. doi: 10.1016/j.ajur.2018.06.001. Epub 2018 Jun 8.
8
The role of fluorescence in situ hybridization to predict patient response to intravesical Bacillus Calmette-Guérin therapy for bladder cancer: A diagnostic meta-analysis and systematic review.荧光原位杂交在预测膀胱癌患者对膀胱内卡介苗治疗反应中的作用:一项诊断性荟萃分析和系统评价。
Medicine (Baltimore). 2018 Sep;97(36):e12227. doi: 10.1097/MD.0000000000012227.
9
Soluble HER3 predicts survival in bladder cancer patients.可溶性HER3可预测膀胱癌患者的生存率。
Oncol Lett. 2018 Feb;15(2):1783-1788. doi: 10.3892/ol.2017.7470. Epub 2017 Nov 22.
10
Role of fluorodeoxyglucose positron emission tomography/computed tomography in diagnostic evaluation of carcinoma urinary bladder: comparison with computed tomography.
World J Nucl Med. 2014 Jan;13(1):34-9. doi: 10.4103/1450-1147.138572.